| Primary information |
|---|
| sequence ID | Seq_3183 |
| Peptide sequence | GSGGGSYGSGGGGGGHGSY |
| CancerPDF_ID | CancerPDF_ID5290, CancerPDF_ID11514, |
| PMID | 24982608,26992070 |
| Protein Name | "Keratin, type II cytoskeletal 1","Keratin, type II cytoskeletal 1" |
| UniprotKB Entry Name | K2C1_HUMAN,K2C1_HUMAN |
| Fluid | Urine,Serum |
| M/Z | NA,NA |
| Charge | NA,NA |
| Mass (in Da) | NA,1514.588182 |
| fdr | NA,NA |
| Profiling Technique | Nano-LC-MS,LC-MS |
| Peptide Identification technique | MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | 0.01,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID5290, CancerPDF_ID11514, |
| p-Value | NA,NA |
| Software | "GPM search engine, MASCOT",SEQUEST and Maxquant |
| Length | 19,19 |
| Cancer Type | Ovarian cancer,Melanoma |
| Database | IPI 3.71 Human Database ,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 6 Ovarian cancer patients and 6 normal individuals,8 cancer samples and 4 healthy samples |
| Regulation | Uniquely present in case of urine of ovarian cancer patients,"Present in 4 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 239759
|